NL-OMON38854已完成不适用
Pharmacokinetics of nAdroparin in venous thromboembolism Prophylaxis in critically ill pAtients - an observational pilot study - The PAPA study
Meander Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* The patient is at least 18 years of age.
- •* The patient is admitted to the intensive care unit.
- •* The patient is already treated with nadroparin for VTE prophylaxis, or, is eligible for treatment with nadroparin for such reasons.
- •* The patient already has a catheter to obtain the necessary blood samples.
排除标准
- •* Acute and life-threatening complications that require immediate patient treatment, as decided by the intensive care physician.
- •* The patient is admitted to the ICU for routine post-operative intensive care monitoring
- •* The patient is treated with a therapeutic dose of nadroparin
研究者
相似试验
尚未招募
不适用
Anticoagulation with nadroparin in continuous venovenous hemofiltration (CVVH): extracorporeal clearance and systemic effects of nadropari(anti)stollingacute renal failurerenal replacement therapy10038430NL-OMON29873Onze Lieve Vrouwe Gasthuis30
Unknown
3 期
Prophylaxis of Venous Thromboembolism in Advanced Lung CancerLung CancerNCT01980849Shengqing Li272
已完成
不适用
Enoxaparin versus control for venous thromboembolic prophylaxis after total knee arthroplasty in Asian patients: a randomized controlled trialosteoarthritis of kneeknee arthroplastyDVT prophylaxisTCTR20140527001Golden Jubilee Medical Center50
进行中（未招募）
1 期
Treatment of thrombosis in the veins with apixabaVenous thrombosis in patients with cancerEUCTR2014-005439-15-NOAkershus University Hospital
已完成
4 期
Nadroparin Anticoagulation for Continuous Venovenous HemofiltrationKidneyAcute Renal FailureMultiple Organ FailureNCT00965328Onze Lieve Vrouwe Gasthuis14